CD40 抗体 (FITC)
Quick Overview for CD40 抗体 (FITC) (ABIN206266)
抗原
See all CD40 抗体适用
宿主
克隆类型
标记
应用范围
- 
    
- 
                                            
纯化方法
 - Protein A purified
 - 
                                            
亚型
 - IgG2a
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - 
                        Approved: Flo (1:1)
Usage: Flow Cytometry: Use 10 μL of the suggested working dilution to label 10^6 cells in 100 μL. Method sheets are available on request. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - 
                                            
说明
 - 
                        
Target Species of Antibody: Human
 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
状态
 - Liquid
 - 
                                            
浓度
 - Lot specific
 - 
                                            
缓冲液
 - PBS, pH 7.4, 0.09 % sodium azide, 1 % BSA.
 - 
                                            
储存液
 - Sodium azide
 - 
                                            
注意事项
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
 - 
                                            
 - 
    
- CD40
 - 
                                            
别名
 - CD40
 - 
                                            
背景
 - 
                        Name/Gene ID: CD40
Family: TNF Receptor
Synonyms: CD40, B-cell surface antigen CD40, B cell-associated molecule, B cell surface antigen CD40, CD40 antigen, CD40 type II isoform, p50, Bp50, CD40L receptor, CDW40, TNFRSF5 - 
                                            
基因ID
 - 958
 - 
                                            
途径
 - NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
 
抗原
 -